+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Targeted Sequencing Market - Cumulative Impact of United States Tariffs 2025 - Global Forecast to 2030- Product Image
Targeted Sequencing Market - Cumulative Impact of United States Tariffs 2025 - Global Forecast to 2030- Product Image
Sale

Targeted Sequencing Market - Cumulative Impact of United States Tariffs 2025 - Global Forecast to 2030

  • PDF Icon

    Report

  • 186 Pages
  • May 2025
  • Region: Global, United States
  • 360iResearch™
  • ID: 5924844
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Targeted Sequencing Market grew from USD 7.60 billion in 2024 to USD 9.18 billion in 2025. It is expected to continue growing at a CAGR of 20.07%, reaching USD 22.78 billion by 2030.

Targeted sequencing has emerged as a pivotal technology in genomics, enabling precise analysis of specific genomic regions with high sensitivity and cost-efficiency. This executive summary provides decision-makers with a concise yet comprehensive overview of the market’s evolving dynamics, major drivers, and strategic imperatives. As research and clinical applications expand-from agricultural genomics to personalized medicine-stakeholders require a clear understanding of the transformative shifts, regulatory impacts, segmentation insights, and competitive landscape shaping this space. Through methodical analysis, this report equips industry leaders with actionable intelligence to navigate supply chain challenges, leverage innovative platforms, and capitalize on regional growth opportunities. By synthesizing the latest technological advances, tariff developments, and company strategies, we deliver an authoritative roadmap for optimizing R&D investment, streamlining operations, and achieving sustainable growth in the targeted sequencing market.

Transformative Shifts Reshaping the Landscape

Over the past decade, targeted sequencing has shifted from a niche research tool to a mainstream solution underpinning clinical diagnostics, drug discovery, and agricultural innovation. Next-generation multiplex amplification workflows have accelerated throughput, while hybridization-capture techniques have enhanced specificity. Concurrently, bioinformatics pipelines have matured, facilitating seamless integration of data analysis into routine workflows. Cost reductions driven by automation in library preparation and scalable sequencing platforms have democratized access to high-resolution genomic profiling.

In parallel, convergence between academic research and commercial R&D has fostered strategic collaborations that expand application horizons. Clinical laboratories now routinely implement cancer panels and inherited disease assays, while agritech firms harness genomic insights for crop improvement and livestock resilience. Meanwhile, service providers and instrumentation vendors are optimizing supply chains and reinforcing quality-control protocols to meet stricter regulatory standards. These transformative shifts underscore the importance of agility and innovation as market participants recalibrate their strategies for a data-driven future.

Cumulative Impact of United States Tariffs in 2025

The tariff adjustments introduced in 2025 have materially altered the economics of importing sequencing reagents, consumables, and instrumentation. Elevated duties on certain molecular biology kits and imported library preparation systems have compelled global players to reassess manufacturing and distribution footprints. Many suppliers have responded by forging strategic partnerships with domestic producers and by localizing key production capabilities to mitigate cost pressures.

Research institutions and clinical labs are reallocating budgets to absorb incremental import costs, spurring demand for alternative vendor agreements and volume-driven pricing models. Instrument manufacturers have accelerated trials of region-specific product configurations to align with evolving duty structures, while some end-users are stockpiling critical reagents to hedge against future tariff uncertainties. As a consequence, supply chains have become more resilient through diversification, thereby enhancing continuity for critical sequencing workflows. This cumulative impact underscores the need for proactive supply-chain management and adaptive pricing strategies.

Key Segmentation Insights and Market Structure

Analysis across core segments reveals a multifaceted market structure beginning with technology type, where amplicon sequencing protocols-spanning PCR-based amplification and probe-based multiplex amplification-coexist alongside custom targeted panels designed for specific genomic loci and hybridization-based capture approaches offering deep enrichment. Application areas range from agricultural genomics, where crop improvement and livestock enhancement drive demand, to clinical diagnostics focusing on oncology and inherited disease detection, as well as drug discovery efforts oriented toward preclinical trials and target identification, and personalized medicine initiatives emphasizing individualized treatment and pharmacogenomic profiling.

End users include large biotechnology companies engaged in clinical trials and product development, hospitals and clinics managing both in-house testing and outsourced services, and research laboratories at academic institutions and government organizations. Product and service offerings span customizable reagent packs and ready-to-use kits, complemented by bioinformatics services and advanced data analysis software. Instrumentation is divided between automated and manual library preparation systems as well as next-generation and real-time sequencing platforms. Understanding the interplay among these segmentations is essential for tailoring value propositions and prioritizing investment in technology enhancements that meet evolving customer requirements.

Key Regional Insights Across Major Geographies

The Americas market continues to benefit from strong pharmaceutical and biotech ecosystems, bolstered by significant R&D funding and well-established precision medicine initiatives. In Europe, Middle East & Africa, robust regulatory frameworks and government-backed genomics programs support innovation, while collaboration across research institutes and clinical networks accelerates technology adoption. The Asia-Pacific region exhibits the fastest growth trajectory, driven by investments in genomic research infrastructure, expanding clinical trials capacity, and supportive policies in emerging economies such as China and India. Cross-regional partnerships and localized manufacturing hubs further enhance accessibility to targeted sequencing solutions, enabling global companies to customize offerings according to regional regulatory requirements, cost structures, and healthcare priorities.

Key Company Insights and Strategic Positioning

The competitive landscape is anchored by established platform leaders delivering high-throughput sequencers and integrated workflows, alongside agile innovators focusing on microfluidic and single-cell targeted assays. Illumina, Roche, and Thermo Fisher maintain dominance through broad reagent portfolios and comprehensive service agreements, while newer entrants such as 10x Genomics and Oxford Nanopore Technologies drive disruption with novel chemistry and real-time analysis capabilities. Meanwhile, companies like QIAGEN, Agilent Technologies, and Takara Bio emphasize customizable panels and streamlined sample processing, and integrators such as PerkinElmer and Bio-Rad Laboratories offer turnkey solutions. Emerging players including Element Biosciences, Singular Genomics Systems, and Paragon Genomics expand the market through strategic alliances, proprietary enrichment methods, and specialized bioinformatics platforms. Collaboration, M&A activity, and co-development partnerships remain critical for sustaining innovation and expanding global reach.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize development of highly multiplexed panels that address both broad disease panels and niche applications. Strengthening in-house bioinformatics capabilities or partnering with specialized data analysis providers will enhance the value proposition by delivering actionable insights. Proactively diversifying supply chains through regional manufacturing partnerships can mitigate tariff and logistics risks, ensuring uninterrupted reagent availability. Engaging with regulatory bodies early in product development fosters smoother clinical validation and market access. Collaborative research programs with academic centers and contract research organizations will accelerate innovation and lower time to market. Focusing on emerging markets by tailoring pricing models and establishing local support networks will capture high-growth opportunities, while investing in workforce training ensures that end users maximize the potential of targeted sequencing solutions.

Conclusion and Strategic Imperatives

Targeted sequencing stands at the confluence of technological innovation, regulatory evolution, and expanding clinical and agricultural applications. As market fragmentation intensifies, success will hinge on balancing platform enhancements with service excellence and strategic partnerships. Leaders who anticipate tariff developments, embrace segment-specific customization, and foster collaborative ecosystems will secure competitive differentiation. By aligning product roadmaps with end-user workflows and regional requirements, companies can transform challenges into growth vectors. Ultimately, a holistic approach integrating technology, data analytics, and market intelligence is essential for sustaining leadership in this dynamic landscape.

Market Segmentation & Coverage

This research report categorizes the Targeted Sequencing Market to forecast the revenues and analyze trends in each of the following sub-segmentations:

  • Amplicon Sequencing
    • PCR-based Amplification
    • Probe-based Multiplex Amplification
  • Custom Targeted Sequencing
    • Customized Panel Design
    • Flexible Custom Sequencing
  • Hybridization-based Targeted Sequencing
    • Capture-based Techniques
    • Enrichment-based Approaches
  • Agricultural Genomics
    • Crop Improvement
    • Livestock Enhancement
  • Clinical Diagnostics
    • Cancer Genomics
    • Inherited Disease Detection
  • Drug Discovery
    • Preclinical Trials
    • Target Identification
  • Personalized Medicine
    • Individualized Treatment
    • Pharmacogenomics
  • Biotechnology Companies
    • Clinical Trials
    • Product Development
  • Hospitals and Clinics
    • In-house Testing
    • Outsourced Services
  • Research Laboratories
    • Academic Institutions
    • Government Organizations
  • Kits and Reagents
    • Customizable Reagent Packs
    • Ready-to-use Kits
  • Software and Services
    • Bioinformatics Services
    • Data Analysis Software
  • Library Preparation Systems
    • Automated Systems
    • Manual Workstations
  • Sequencing Platforms
    • Next-generation Sequencers
    • Real-time Sequencers

This research report categorizes the Targeted Sequencing Market to forecast the revenues and analyze trends in each of the following sub-regions:

  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Europe, Middle East & Africa
    • Denmark
    • Egypt
    • Finland
    • France
    • Germany
    • Israel
    • Italy
    • Netherlands
    • Nigeria
    • Norway
    • Poland
    • Qatar
    • Russia
    • Saudi Arabia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Turkey
    • United Arab Emirates
    • United Kingdom

This research report categorizes the Targeted Sequencing Market to delves into recent significant developments and analyze trends in each of the following companies:

  • 10x Genomics, Inc.
  • A-Alpha Bio, Inc.
  • Agilent Technologies, Inc.
  • Azenta Life Sciences
  • BGI Genomics Co., Ltd.
  • Bio-Rad Laboratories, Inc.
  • CD Genomics
  • DH Life Sciences, LLC
  • Element Biosciences
  • F. Hoffmann-La Roche Ltd.
  • Illumina, Inc.
  • LGC Limited
  • Macrogen, Inc.
  • MGI Tech Co., Ltd.
  • Oxford Nanopore Technologies PLC
  • Pacific Biosciences of California, Inc.
  • Paragon Genomics, Inc.
  • PerkinElmer, Inc.
  • Psomagen, Inc.
  • QIAGEN N.V.
  • Singular Genomics Systems, Inc.
  • Takara Bio Inc.
  • Tecan Trading AG
  • Thermo Fisher Scientific Inc.
  • Twist Bioscience Corporation

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Targeted Sequencing Market, by Technology Type
8.1. Introduction
8.2. Amplicon Sequencing
8.2.1. PCR-based Amplification
8.2.2. Probe-based Multiplex Amplification
8.3. Custom Targeted Sequencing
8.3.1. Customized Panel Design
8.3.2. Flexible Custom Sequencing
8.4. Hybridization-based Targeted Sequencing
8.4.1. Capture-based Techniques
8.4.2. Enrichment-based Approaches
9. Targeted Sequencing Market, by Application
9.1. Introduction
9.2. Agricultural Genomics
9.2.1. Crop Improvement
9.2.2. Livestock Enhancement
9.3. Clinical Diagnostics
9.3.1. Cancer Genomics
9.3.2. Inherited Disease Detection
9.4. Drug Discovery
9.4.1. Preclinical Trials
9.4.2. Target Identification
9.5. Personalized Medicine
9.5.1. Individualized Treatment
9.5.2. Pharmacogenomics
10. Targeted Sequencing Market, by End User
10.1. Introduction
10.2. Biotechnology Companies
10.2.1. Clinical Trials
10.2.2. Product Development
10.3. Hospitals and Clinics
10.3.1. In-house Testing
10.3.2. Outsourced Services
10.4. Research Laboratories
10.4.1. Academic Institutions
10.4.2. Government Organizations
11. Targeted Sequencing Market, by Product and Services
11.1. Introduction
11.2. Kits and Reagents
11.2.1. Customizable Reagent Packs
11.2.2. Ready-to-use Kits
11.3. Software and Services
11.3.1. Bioinformatics Services
11.3.2. Data Analysis Software
12. Targeted Sequencing Market, by Instrument Type
12.1. Introduction
12.2. Library Preparation Systems
12.2.1. Automated Systems
12.2.2. Manual Workstations
12.3. Sequencing Platforms
12.3.1. Next-generation Sequencers
12.3.2. Real-time Sequencers
13. Americas Targeted Sequencing Market
13.1. Introduction
13.2. Argentina
13.3. Brazil
13.4. Canada
13.5. Mexico
13.6. United States
14. Asia-Pacific Targeted Sequencing Market
14.1. Introduction
14.2. Australia
14.3. China
14.4. India
14.5. Indonesia
14.6. Japan
14.7. Malaysia
14.8. Philippines
14.9. Singapore
14.10. South Korea
14.11. Taiwan
14.12. Thailand
14.13. Vietnam
15. Europe, Middle East & Africa Targeted Sequencing Market
15.1. Introduction
15.2. Denmark
15.3. Egypt
15.4. Finland
15.5. France
15.6. Germany
15.7. Israel
15.8. Italy
15.9. Netherlands
15.10. Nigeria
15.11. Norway
15.12. Poland
15.13. Qatar
15.14. Russia
15.15. Saudi Arabia
15.16. South Africa
15.17. Spain
15.18. Sweden
15.19. Switzerland
15.20. Turkey
15.21. United Arab Emirates
15.22. United Kingdom
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. 10x Genomics, Inc.
16.3.2. A-Alpha Bio, Inc.
16.3.3. Agilent Technologies, Inc.
16.3.4. Azenta Life Sciences
16.3.5. BGI Genomics Co., Ltd.
16.3.6. Bio-Rad Laboratories, Inc.
16.3.7. CD Genomics
16.3.8. DH Life Sciences, LLC
16.3.9. Element Biosciences
16.3.10. F. Hoffmann-La Roche Ltd.
16.3.11. Illumina, Inc.
16.3.12. LGC Limited
16.3.13. Macrogen, Inc.
16.3.14. MGI Tech Co., Ltd.
16.3.15. Oxford Nanopore Technologies PLC
16.3.16. Pacific Biosciences of California, Inc.
16.3.17. Paragon Genomics, Inc.
16.3.18. PerkinElmer, Inc.
16.3.19. Psomagen, Inc.
16.3.20. QIAGEN N.V.
16.3.21. Singular Genomics Systems, Inc.
16.3.22. Takara Bio Inc.
16.3.23. Tecan Trading AG
16.3.24. Thermo Fisher Scientific Inc.
16.3.25. Twist Bioscience Corporation
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. TARGETED SEQUENCING MARKET MULTI-CURRENCY
FIGURE 2. TARGETED SEQUENCING MARKET MULTI-LANGUAGE
FIGURE 3. TARGETED SEQUENCING MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL TARGETED SEQUENCING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY TECHNOLOGY TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY TECHNOLOGY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY PRODUCT AND SERVICES, 2024 VS 2030 (%)
FIGURE 14. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY PRODUCT AND SERVICES, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY INSTRUMENT TYPE, 2024 VS 2030 (%)
FIGURE 16. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY INSTRUMENT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS TARGETED SEQUENCING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS TARGETED SEQUENCING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES TARGETED SEQUENCING MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES TARGETED SEQUENCING MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC TARGETED SEQUENCING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC TARGETED SEQUENCING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA TARGETED SEQUENCING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA TARGETED SEQUENCING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. TARGETED SEQUENCING MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. TARGETED SEQUENCING MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. TARGETED SEQUENCING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL TARGETED SEQUENCING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY AMPLICON SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY PCR-BASED AMPLIFICATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY PROBE-BASED MULTIPLEX AMPLIFICATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY AMPLICON SEQUENCING, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY CUSTOM TARGETED SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY CUSTOMIZED PANEL DESIGN, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY FLEXIBLE CUSTOM SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY CUSTOM TARGETED SEQUENCING, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY HYBRIDIZATION-BASED TARGETED SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY CAPTURE-BASED TECHNIQUES, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY ENRICHMENT-BASED APPROACHES, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY HYBRIDIZATION-BASED TARGETED SEQUENCING, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY AGRICULTURAL GENOMICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY CROP IMPROVEMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY LIVESTOCK ENHANCEMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY AGRICULTURAL GENOMICS, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY CANCER GENOMICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY INHERITED DISEASE DETECTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY PRECLINICAL TRIALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY TARGET IDENTIFICATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY PERSONALIZED MEDICINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY INDIVIDUALIZED TREATMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY PHARMACOGENOMICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY PERSONALIZED MEDICINE, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY CLINICAL TRIALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY PRODUCT DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY IN-HOUSE TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY OUTSOURCED SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY RESEARCH LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY ACADEMIC INSTITUTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY GOVERNMENT ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY PRODUCT AND SERVICES, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY KITS AND REAGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY CUSTOMIZABLE REAGENT PACKS, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY READY-TO-USE KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY KITS AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY SOFTWARE AND SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY BIOINFORMATICS SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY DATA ANALYSIS SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY INSTRUMENT TYPE, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY LIBRARY PREPARATION SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY AUTOMATED SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY MANUAL WORKSTATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY LIBRARY PREPARATION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 63. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY SEQUENCING PLATFORMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 64. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY NEXT-GENERATION SEQUENCERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 65. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY REAL-TIME SEQUENCERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 66. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY SEQUENCING PLATFORMS, 2018-2030 (USD MILLION)
TABLE 67. AMERICAS TARGETED SEQUENCING MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 68. AMERICAS TARGETED SEQUENCING MARKET SIZE, BY AMPLICON SEQUENCING, 2018-2030 (USD MILLION)
TABLE 69. AMERICAS TARGETED SEQUENCING MARKET SIZE, BY CUSTOM TARGETED SEQUENCING, 2018-2030 (USD MILLION)
TABLE 70. AMERICAS TARGETED SEQUENCING MARKET SIZE, BY HYBRIDIZATION-BASED TARGETED SEQUENCING, 2018-2030 (USD MILLION)
TABLE 71. AMERICAS TARGETED SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 72. AMERICAS TARGETED SEQUENCING MARKET SIZE, BY AGRICULTURAL GENOMICS, 2018-2030 (USD MILLION)
TABLE 73. AMERICAS TARGETED SEQUENCING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 74. AMERICAS TARGETED SEQUENCING MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 75. AMERICAS TARGETED SEQUENCING MARKET SIZE, BY PERSONALIZED MEDICINE, 2018-2030 (USD MILLION)
TABLE 76. AMERICAS TARGETED SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 77. AMERICAS TARGETED SEQUENCING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 78. AMERICAS TARGETED SEQUENCING MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 79. AMERICAS TARGETED SEQUENCING MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
TABLE 80. AMERICAS TARGETED SEQUENCING MARKET SIZE, BY PRODUCT AND SERVICES, 2018-2030 (USD MILLION)
TABLE 81. AMERICAS TARGETED SEQUENCING MARKET SIZE, BY KITS AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 82. AMERICAS TARGETED SEQUENCING MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2030 (USD MILLION)
TABLE 83. AMERICAS TARGETED SEQUENCING MARKET SIZE, BY INSTRUMENT TYPE, 2018-2030 (USD MILLION)
TABLE 84. AMERICAS TARGETED SEQUENCING MARKET SIZE, BY LIBRARY PREPARATION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 85. AMERICAS TARGETED SEQUENCING MARKET SIZE, BY SEQUENCING PLATFORMS, 2018-2030 (USD MILLION)
TABLE 86. AMERICAS TARGETED SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 87. ARGENTINA TARGETED SEQUENCING MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 88. ARGENTINA TARGETED SEQUENCING MARKET SIZE, BY AMPLICON SEQUENCING, 2018-2030 (USD MILLION)
TABLE 89. ARGENTINA TARGETED SEQUENCING MARKET SIZE, BY CUSTOM TARGETED SEQUENCING, 2018-2030 (USD MILLION)
TABLE 90. ARGENTINA TARGETED SEQUENCING MARKET SIZE, BY HYBRIDIZATION-BASED TARGETED SEQUENCING, 2018-2030 (USD MILLION)
TABLE 91. ARGENTINA TARGETED SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 92. ARGENTINA TARGETED SEQUENCING MARKET SIZE, BY AGRICULTURAL GENOMICS, 2018-2030 (USD MILLION)
TABLE 93. ARGENTINA TARGETED SEQUENCING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 94. ARGENTINA TARGETED SEQUENCING MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 95. ARGENTINA TARGETED SEQUENCING MARKET SIZE, BY PERSONALIZED MEDICINE, 2018-2030 (USD MILLION)
TABLE 96. ARGENTINA TARGETED SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 97. ARGENTINA TARGETED SEQUENCING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 98. ARGENTINA TARGETED SEQUENCING MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 99. ARGENTINA TARGETED SEQUENCING MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
TABLE 100. ARGENTINA TARGETED SEQUENCING MARKET SIZE, BY PRODUCT AND SERVICES, 2018-2030 (USD MILLION)
TABLE 101. ARGENTINA TARGETED SEQUENCING MARKET SIZE, BY KITS AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 102. ARGENTINA TARGETED SEQUENCING MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2030 (USD MILLION)
TABLE 103. ARGENTINA TARGETED SEQUENCING MARKET SIZE, BY INSTRUMENT TYPE, 2018-2030 (USD MILLION)
TABLE 104. ARGENTINA TARGETED SEQUENCING MARKET SIZE, BY LIBRARY PREPARATION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 105. ARGENTINA TARGETED SEQUENCING MARKET SIZE, BY SEQUENCING PLATFORMS, 2018-2030 (USD MILLION)
TABLE 106. BRAZIL TARGETED SEQUENCING MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 107. BRAZIL TARGETED SEQUENCING MARKET SIZE, BY AMPLICON SEQUENCING, 2018-2030 (USD MILLION)
TABLE 108. BRAZIL TARGETED SEQUENCING MARKET SIZE, BY CUSTOM TARGETED SEQUENCING, 2018-2030 (USD MILLION)
TABLE 109. BRAZIL TARGETED SEQUENCING MARKET SIZE, BY HYBRIDIZATION-BASED TARGETED SEQUENCING, 2018-2030 (USD MILLION)
TABLE 110. BRAZIL TARGETED SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 111. BRAZIL TARGETED SEQUENCING MARKET SIZE, BY AGRICULTURAL GENOMICS, 2018-2030 (USD MILLION)
TABLE 112. BRAZIL TARGETED SEQUENCING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 113. BRAZIL TARGETED SEQUENCING MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 114. BRAZIL TARGETED SEQUENCING MARKET SIZE, BY PERSONALIZED MEDICINE, 2018-2030 (USD MILLION)
TABLE 115. BRAZIL TARGETED SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 116. BRAZIL TARGETED SEQUENCING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 117. BRAZIL TARGETED SEQUENCING MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 118. BRAZIL TARGETED SEQUENCING MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
TABLE 119. BRAZIL TARGETED SEQUENCING MARKET SIZE, BY PRODUCT AND SERVICES, 2018-2030 (USD MILLION)
TABLE 120. BRAZIL TARGETED SEQUENCING MARKET SIZE, BY KITS AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 121. BRAZIL TARGETED SEQUENCING MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2030 (USD MILLION)
TABLE 122. BRAZIL TARGETED SEQUENCING MARKET SIZE, BY INSTRUMENT TYPE, 2018-2030 (USD MILLION)
TABLE 123. BRAZIL TARGETED SEQUENCING MARKET SIZE, BY LIBRARY PREPARATION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 124. BRAZIL TARGETED SEQUENCING MARKET SIZE, BY SEQUENCING PLATFORMS, 2018-2030 (USD MILLION)
TABLE 125. CANADA TARGETED SEQUENCING MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 126. CANADA TARGETED SEQUENCING MARKET SIZE, BY AMPLICON SEQUENCING, 2018-2030 (USD MILLION)
TABLE 127. CANADA TARGETED SEQUENCING MARKET SIZE, BY CUSTOM TARGETED SEQUENCING, 2018-2030 (USD MILLION)
TABLE 128. CANADA TARGETED SEQUENCING MARKET SIZE, BY HYBRIDIZATION-BASED TARGETED SEQUENCING, 2018-2030 (USD MILLION)
TABLE 129. CANADA TARGETED SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 130. CANADA TARGETED SEQUENCING MARKET SIZE, BY AGRICULTURAL GENOMICS, 2018-2030 (USD MILLION)
TABLE 131. CANADA TARGETED SEQUENCING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 132. CANADA TARGETED SEQUENCING MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 133. CANADA TARGETED SEQUENCING MARKET SIZE, BY PERSONALIZED MEDICINE, 2018-2030 (USD MILLION)
TABLE 134. CANADA TARGETED SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 135. CANADA TARGETED SEQUENCING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 136. CANADA TARGETED SEQUENCING MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 137. CANADA TARGETED SEQUENCING MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
TABLE 138. CANADA TARGETED SEQUENCING MARKET SIZE, BY PRODUCT AND SERVICES, 2018-2030 (USD MILLION)
TABLE 139. CANADA TARGETED SEQUENCING MARKET SIZE, BY KITS AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 140. CANADA TARGETED SEQUENCING MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2030 (USD MILLION)
TABLE 141. CANADA TARGETED SEQUENCING MARKET SIZE, BY INSTRUMENT TYPE, 2018-2030 (USD MILLION)
TABLE 142. CANADA TARGETED SEQUENCING MARKET SIZE, BY LIBRARY PREPARATION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 143. CANADA TARGETED SEQUENCING MARKET SIZE, BY SEQUENCING PLATFORMS, 2018-2030 (USD MILLION)
TABLE 144. MEXICO TARGETED SEQUENCING MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 145. MEXICO TARGETED SEQUENCING MARKET SIZE, BY AMPLICON SEQUENCING, 2018-2030 (USD MILLION)
TABLE 146. MEXICO TARGETED SEQUENCING MARKET SIZE, BY CUSTOM TARGETED SEQUENCING, 2018-2030 (USD MILLION)
TABLE 147. MEXICO TARGETED SEQUENCING MARKET SIZE, BY HYBRIDIZATION-BASED TARGETED SEQUENCING, 2018-2030 (USD MILLION)
TABLE 148. MEXICO TARGETED SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 149. MEXICO TARGETED SEQUENCING MARKET SIZE, BY AGRICULTURAL GENOMICS, 2018-2030 (USD MILLION)
TABLE 150. MEXICO TARGETED SEQUENCING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 151. MEXICO TARGETED SEQUENCING MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 152. MEXICO TARGETED SEQUENCING MARKET SIZE, BY PERSONALIZED MEDICINE, 2018-2030 (USD MILLION)
TABLE 153. MEXICO TARGETED SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 154. MEXICO TARGETED SEQUENCING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 155. MEXICO TARGETED SEQUENCING MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 156. MEXICO TARGETED SEQUENCING MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
TABLE 157. MEXICO TARGETED SEQUENCING MARKET SIZE, BY PRODUCT AND SERVICES, 2018-2030 (USD MILLION)
TABLE 158. MEXICO TARGETED SEQUENCING MARKET SIZE, BY KITS AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 159. MEXICO TARGETED SEQUENCING MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2030 (USD MILLION)
TABLE 160. MEXICO TARGETED SEQUENCING MARKET SIZE, BY INSTRUMENT TYPE, 2018-2030 (USD MILLION)
TABLE 161. MEXICO TARGETED SEQUENCING MARKET SIZE, BY LIBRARY PREPARATION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 162. MEXICO TARGETED SEQUENCING MARKET SIZE, BY SEQUENCING PLATFORMS, 2018-2030 (USD MILLION)
TABLE 163. UNITED STATES TARGETED SEQUENCING MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 164. UNITED STATES TARGETED SEQUENCING MARKET SIZE, BY AMPLICON SEQUENCING, 2018-2030 (USD MILLION)
TABLE 165. UNITED STATES TARGETED SEQUENCING MARKET SIZE, BY CUSTOM TARGETED SEQUENCING, 2018-2030 (USD MILLION)
TABLE 166. UNITED STATES TARGETED SEQUENCING MARKET SIZE, BY HYBRIDIZATION-BASED TARGETED SEQUENCING, 2018-2030 (USD MILLION)
TABLE 167. UNITED STATES TARGETED SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 168. UNITED STATES TARGETED SEQUENCING MARKET SIZE, BY AGRICULTURAL GENOMICS, 2018-2030 (USD MILLION)
TABLE 169. UNITED STATES TARGETED SEQUENCING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 170. UNITED STATES TARGETED SEQUENCING MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 171. UNITED STATES TARGETED SEQUENCING MARKET SIZE, BY PERSONALIZED MEDICINE, 2018-2030 (USD MILLION)
TABLE 172. UNITED STATES TARGETED SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 173. UNITED STATES TARGETED SEQUENCING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 174. UNITED STATES TARGETED SEQUENCING MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 175. UNITED STATES TARGETED SEQUENCING MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
TABLE 176. UNITED STATES TARGETED SEQUENCING MARKET SIZE, BY PRODUCT AND SERVICES, 2018-2030 (USD MILLION)
TABLE 177. UNITED STATES TARGETED SEQUENCING MARKET SIZE, BY KITS AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 178. UNITED STATES TARGETED SEQUENCING MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2030 (USD MILLION)
TABLE 179. UNITED STATES TARGETED SEQUENCING MARKET SIZE, BY INSTRUMENT TYPE, 2018-2030 (USD MILLION)
TABLE 180. UNITED STATES TARGETED SEQUENCING MARKET SIZE, BY LIBRARY PREPARATION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 181. UNITED STATES TARGETED SEQUENCING MARKET SIZE, BY SEQUENCING PLATFORMS, 2018-2030 (USD MILLION)
TABLE 182. UNITED STATES TARGETED SEQUENCING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 183. ASIA-PACIFIC TARGETED SEQUENCING MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 184. ASIA-PACIFIC TARGETED SEQUENCING MARKET SIZE, BY AMPLICON SEQUENCING, 2018-2030 (USD MILLION)
TABLE 185. ASIA-PACIFIC TARGETED SEQUENCING MARKET SIZE, BY CUSTOM TARGETED SEQUENCING, 2018-2030 (USD MILLION)
TABLE 186. ASIA-PACIFIC TARGETED SEQUENCING MARKET SIZE, BY HYBRIDIZATION-BASED TARGETED SEQUENCING, 2018-2030 (USD MILLION)
TABLE 187. ASIA-PACIFIC TARGETED SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 188. ASIA-PACIFIC TARGETED SEQUENCING MARKET SIZE, BY AGRICULTURAL GENOMICS, 2018-2030 (USD MILLION)
TABLE 189. ASIA-PACIFIC TARGETED SEQUENCING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 190. ASIA-PACIFIC TARGETED SEQUENCING MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 191. ASIA-PACIFIC TARGETED SEQUENCING MARKET SIZE, BY PERSONALIZED MEDICINE, 2018-2030 (USD MILLION)
TABLE 192. ASIA-PACIFIC TARGETED SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 193. ASIA-PACIFIC TARGETED SEQUENCING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 194. ASIA-PACIFIC TARGETED SEQUENCING MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 195. ASIA-PACIFIC TARGETED SEQUENCING MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
TABLE 196. ASIA-PACIFIC TARGETED SEQUENCING MARKET SIZE, BY PRODUCT AND SERVICES, 2018-2030 (USD MILLION)
TABLE 197. ASIA-PACIFIC TARGETED SEQUENCING MARKET SIZE, BY KITS AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 198. ASIA-PACIFIC TARGETED SEQUENCING MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2030 (USD MILLION)
TABLE 199. ASIA-PACIFIC TARGETED SEQUENCING MARKET SIZE, BY INSTRUMENT TYPE, 2018-2030 (USD MILLION)
TABLE 200. ASIA-PACIFIC TARGETED SEQUENCING MARKET SIZE, BY LIBRARY PREPARATION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 201. ASIA-PACIFIC TARGETED SEQUENCING MARKET SIZE, BY SEQUENCING PLATFORMS, 2018-2030 (USD MILLION)
TABLE 202. ASIA-PACIFIC TARGETED SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 203. AUSTRALIA TARGETED SEQUENCING MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 204. AUSTRALIA TARGETED SEQUENCING MARKET SIZE, BY AMPLICON SEQUENCING, 2018-2030 (USD MILLION)
TABLE 205. AUSTRALIA TARGETED SEQUENCING MARKET SIZE, BY CUSTOM TARGETED SEQUENCING, 2018-2030 (USD MILLION)
TABLE 206. AUSTRALIA TARGETED SEQUENCING MARKET SIZE, BY HYBRIDIZATION-BASED TARGETED SEQUENCING, 2018-2030 (USD MILLION)
TABLE 207. AUSTRALIA TARGETED SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 208. AUSTRALIA TARGETED SEQUENCING MARKET SIZE, BY AGRICULTURAL GENOMICS, 2018-2030 (USD MILLION)
TABLE 209. AUSTRALIA TARGETED SEQUENCING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 210. AUSTRALIA TARGETED SEQUENCING MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 211. AUSTRALIA TARGETED SEQUENCING MARKET SIZE, BY PERSONALIZED MEDICINE, 2018-2030 (USD MILLION)
TABLE 212. AUSTRALIA TARGETED SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 213. AUSTRALIA TARGETED SEQUENCING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 214. AUSTRALIA TARGETED SEQUENCING MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 215. AUSTRALIA TARGETED SEQUENCING MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
TABLE 216. AUSTRALIA TARGETED SEQUENCING MARKET SIZE, BY PRODUCT AND SERVICES, 2018-2030 (USD MILLION)
TABLE 217. AUSTRALIA TARGETED SEQUENCING MARKET SIZE, BY KITS AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 218. AUSTRALIA TARGETED SEQUENCING MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2030 (USD MILLION)
TABLE 219. AUSTRALIA TARGETED SEQUENCING MARKET SIZE, BY INSTRUMENT TYPE, 2018-2030 (USD MILLION)
TABLE 220. AUSTRALIA TARGETED SEQUENCING MARKET SIZE, BY LIBRARY PREPARATION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 221. AUSTRALIA TARGETED SEQUENCING MARKET SIZE, BY SEQUENCING PLATFORMS, 2018-2030 (USD MILLION)
TABLE 222. CHINA TARGETED SEQUENCING MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 223. CHINA TARGETED SEQUENCING MARKET SIZE, BY AMPLICON SEQUENCING, 2018-2030 (USD MILLION)
TABLE 224. CHINA TARGETED SEQUENCING MARKET SIZE, BY CUSTOM TARGETED SEQUENCING, 2018-2030 (USD MILLION)
TABLE 225. CHINA TARGETED SEQUENCING MARKET SIZE, BY HYBRIDIZATION-BASED TARGETED SEQUENCING, 2018-2030 (USD MILLION)
TABLE 226. CHINA TARGETED SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 227. CHINA TARGETED SEQUENCING MARKET SIZE, BY AGRICULTURAL GENOMICS, 2018-2030 (USD MILLION)
TABLE 228. CHINA TARGETED SEQUENCING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 229. CHINA TARGETED SEQUENCING MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 230. CHINA TARGETED SEQUENCING MARKET SIZE, BY PERSONALIZED MEDICINE, 2018-2030 (USD MILLION)
TABLE 231. CHINA TARGETED SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 232. CHINA TARGETED SEQUENCING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 233. CHINA TARGETED SEQUENCING MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 234. CHINA TARGETED SEQUENCING MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
TABLE 235. CHINA TARGETED SEQUENCING MARKET SIZE, BY PRODUCT AND SERVICES, 2018-2030 (USD MILLION)
TABLE 236. CHINA TARGETED SEQUENCING MARKET SIZE, BY KITS AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 237. CHINA TARGETED SEQUENCING MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2030 (USD MILLION)
TABLE 238. CHINA TARGETED SEQUENCING MARKET SIZE, BY INSTRUMENT TYPE, 2018-2030 (USD MILLION)
TABLE 239. CHINA TARGETED SEQUENCING MARKET SIZE, BY LIBRARY PREPARATION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 240. CHINA TARGETED SEQUENCING MARKET SIZE, BY SEQUENCING PLATFORMS, 2018-2030 (USD MILLION)
TABLE 241. INDIA TARGETED SEQUENCING MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 242. INDIA TARGETED SEQUENCING MARKET SIZE, BY AMPLICON SEQUENCING, 2018-2030 (USD MILLION)
TABLE 243. INDIA TARGETED SEQUENCING MARKET SIZE, BY CUSTOM TARGETED SEQUENCING, 2018-2030 (USD MILLION)
TABLE 244. INDIA TARGETED SEQUENCING MARKET SIZE, BY HYBRIDIZATION-BASED TARGETED SEQUENCING, 2018-2030 (USD MILLION)
TABLE 245. INDIA TARGETED SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 246. INDIA TARGETED SEQUENCING MARKET SIZE, BY AGRICULTURAL GENOMICS, 2018-2030 (USD MILLION)
TABLE 247. INDIA TARGETED SEQUENCING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 248. INDIA TARGETED SEQUENCING MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 249. INDIA TARGETED SEQUENCING MARKET SIZE, BY PERSONALIZED MEDICINE, 2018-2030 (USD MILLION)
TABLE 250. INDIA TARGETED SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 251. INDIA TARGETED SEQUENCING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 252. INDIA TARGETED SEQUENCING MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 253. INDIA TARGETED SEQUENCING MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
TABLE 254. INDIA TARGETED SEQUENCING MARKET SIZE, BY PRODUCT AND SERVICES, 2018-2030 (USD MILLION)
TABLE 255. INDIA TARGETED SEQUENCING MARKET SIZE, BY KITS AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 256. INDIA TARGETED SEQUENCING MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2030 (USD MILLION)
TABLE 257. INDIA TARGETED SEQUENCING MARKET SIZE, BY INSTRUMENT TYPE, 2018-2030 (USD MILLION)
TABLE 258. INDIA TARGETED SEQUENCING MARKET SIZE, BY LIBRARY PREPARATION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 259. INDIA TARGETED SEQUENCING MARKET SIZE, BY SEQUENCING PLATFORMS, 2018-2030 (USD MILLION)
TABLE 260. INDONESIA TARGETED SEQUENCING MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 261. INDONESIA TARGETED SEQUENCING MARKET SIZE, BY AMPLICON SEQUENCING, 2018-2030 (USD MILLION)
TABLE 262. INDONESIA TARGETED SEQUENCING MARKET SIZE, BY CUSTOM TARGETED SEQUENCING, 2018-2030 (USD MILLION)
TABLE 263. INDONESIA TARGETED SEQUENCING MARKET SIZE, BY HYBRIDIZATION-BASED TARGETED SEQUENCING, 2018-2030 (USD MILLION)
TABLE 264. INDONESIA TARGETED SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 265. INDONESIA TARGETED SEQUENCING MARKET SIZE, BY AGRICULTURAL GENOMICS, 2018-2030 (USD MILLION)
TABLE 266. INDONESIA TARGETED SEQUENCING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 267. INDONESIA TARGETED SEQUENCING MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 268. INDONESIA TARGETED SEQUENCING MARKET SIZE, BY PERSONALIZED MEDICINE, 2018-2030 (USD MILLION)
TABLE 269. INDONESIA TARGETED SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 270. INDONESIA TARGETED SEQUENCING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 271. INDONESIA TARGETED SEQUENCING MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 272. INDONESIA TARGETED SEQUENCING MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
TABLE 273. INDONESIA TARGETED SEQUENCING MARKET SIZE, BY PRODUCT AND SERVICES, 2018-2030 (USD MILLION)
TABLE 274. INDONESIA TARGETED SEQUENCING MARKET SIZE, BY KITS AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 275. INDONESIA TARGETED SEQUENCING MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2030 (USD MILLION)
TABLE 276. INDONESIA TARGETED SEQUENCING MARKET SIZE, BY INSTRUMENT TYPE, 2018-2030 (USD MILLION)
TABLE 277. INDONESIA TARGETED SEQUENCING MARKET SIZE, BY LIBRARY PREPARATION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 278. INDONESIA TARGETED SEQUENCING MARKET SIZE, BY SEQUENCING PLATFORMS, 2018-2030 (USD MILLION)
TABLE 279. JAPAN TARGETED SEQUENCING MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 280. JAPAN TARGETED SEQUENCING MARKET SIZE, BY AMPLICON SEQUENCING, 2018-2030 (USD MILLION)
TABLE 281. JAPAN TARGETED SEQUENCING MARKET SIZE, BY CUSTOM TARGETED SEQUENCING, 2018-2030 (USD MILLION)
TABLE 282. JAPAN TARGETED SEQUENCING MARKET SIZE, BY HYBRIDIZATION-BASED TARGETED SEQUENCING, 2018-2030 (USD MILLION)
TABLE 283. JAPAN TARGETED SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 284. JAPAN TARGETED SEQUENCING MARKET SIZE, BY AGRICULTURAL GENOMICS, 2018-2030 (USD MILLION)
TABLE 285. JAPAN TARGETED SEQUENCING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 286. JAPAN TARGETED SEQUENCING MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 287. JAPAN TARGETED SEQUENCING MARKET SIZE, BY PERSONALIZED MEDICINE, 2018-2030 (USD MILLION)
TABLE 288. JAPAN TARGETED SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 289. JAPAN TARGETED SEQUENCING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 290. JAPAN TARGETED SEQUENCING MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 291. JAPAN TARGETED SEQUENCING MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
TABLE 292. JAPAN TARGETED SEQUENCING MARKET SIZE, BY PRODUCT AND SERVICES, 2018-2030 (USD MILLION)
TABLE 293. JAPAN TARGETED SEQUENCING MARKET SIZE, BY KITS AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 294. JAPAN TARGETED SEQUENCING MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2030 (USD MILLION)
TABLE 295. JAPAN TARGETED SEQUENCING MARKET SIZE, BY INSTRUMENT TYPE, 2018-2030 (USD MILLION)
TABLE 296. JAPAN TARGETED SEQUENCING MARKET SIZE, BY LIBRARY PREPARATION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 297. JAPAN TARGETED SEQUENCING MARKET SIZE, BY SEQUENCING PLATFORMS, 2018-2030 (USD MILLION)
TABLE 298. MALAYSIA TARGETED SEQUENCING MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 299. MALAYSIA TARGETED SEQUENCING MARKET SIZE, BY AMPLICON SEQUENCING, 2018-2030 (USD MILLION)
TABLE 300. MALAYSIA TARGETED SEQUENCING MARKET SIZE, BY CUSTOM TARGETED SEQUENCING, 2018-2030 (USD MILLION)
TABLE 301. MALAYSIA TARGETED SEQUENCING MARKET SIZE, BY HYBRIDIZATION-BASED TARGETED SEQUENCING, 2018-2030 (USD MILLION)
TABLE 302. MALAYSIA TARGETED SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 303. MALAYSIA TARGETED SEQUENCING MARKET SIZE, BY AGRICULTURAL GENOMICS, 2018-2030 (USD MILLION)
TABLE 304. MALAYSIA TARGETED SEQUENCING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 305. MALAYSIA TARGETED SEQUENCING MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 306. MALAYSIA TARGETED SEQUENCING MARKET SIZE, BY PERSONALIZED MEDICINE, 2018-2030 (USD MILLION)
TABLE 307. MALAYSIA TARGETED SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 308. MALAYSIA TARGETED SEQUENCING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 309. MALAYSIA TARGETED SEQUENCING MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 310. MALAYSIA TARGETED SEQUENCING MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
TABLE 311. MALAYSIA TARGETED SEQUENCING MARKET SIZE, BY PRODUCT AND SERVICES, 2018-2030 (USD MILLION)
TABLE 312. MALAYSIA TARGETED SEQUENCING MARKET SIZE, BY KITS AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 313. MALAYSIA TARGETED SEQUENCING MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2030 (USD MILLION)
TABLE 314. MALAYSIA TARGETED SEQUENCING MARKET SIZE, BY INSTRUMENT TYPE, 2018-2030 (USD MILLION)
TABLE 315. MALAYSIA TARGETED SEQUENCING MARKET SIZE, BY LIBRARY PREPARATION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 316. MALAYSIA TARGETED SEQUENCING MARKET SIZE, BY SEQUENCING PLATFORMS, 2018-2030 (USD MILLION)
TABLE 317. PHILIPPINES TARGETED SEQUENCING MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 318. PHILIPPINES TARGETED SEQUENCING MARKET SIZE, BY AMPLICON SEQUENCING, 2018-2030 (USD MILLION)
TABLE 319. PHILIPPINES TARGETED SEQUENCING MARKET SIZE, BY CUSTOM TARGETED SEQUENCING, 2018-2030 (USD MILLION)
TABLE 320. PHILIPPINES TARGETED SEQUENCING MARKET SIZE, BY HYBRIDIZATION-BASED TARGETED SEQUENCING, 2018-2030 (USD MILLION)
TABLE 321. PHILIPPINES TARGETED SEQUEN

Companies Mentioned

  • 10x Genomics, Inc.
  • A-Alpha Bio, Inc.
  • Agilent Technologies, Inc.
  • Azenta Life Sciences
  • BGI Genomics Co., Ltd.
  • Bio-Rad Laboratories, Inc.
  • CD Genomics
  • DH Life Sciences, LLC
  • Element Biosciences
  • F. Hoffmann-La Roche Ltd.
  • Illumina, Inc.
  • LGC Limited
  • Macrogen, Inc.
  • MGI Tech Co., Ltd.
  • Oxford Nanopore Technologies PLC
  • Pacific Biosciences of California, Inc.
  • Paragon Genomics, Inc.
  • PerkinElmer, Inc.
  • Psomagen, Inc.
  • QIAGEN N.V.
  • Singular Genomics Systems, Inc.
  • Takara Bio Inc.
  • Tecan Trading AG
  • Thermo Fisher Scientific Inc.
  • Twist Bioscience Corporation

Methodology

Loading
LOADING...

Related Topics

Related Reports

Targeted Sequencing and Resequencing - Global Strategic Business Report - Product Image

Targeted Sequencing and Resequencing - Global Strategic Business Report

  • Report
  • 72 Pages
  • Global
From
Targeted Sequencing And Resequencing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F - Product Image

Targeted Sequencing And Resequencing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F

  • Report
  • 187 Pages
  • Global
From
Targeted DNA RNA Sequencing Market Size, Share & Trends Analysis Report By Product (NGS), By Workflow (Pre-sequencing), By Application, By Technology, By Type, By End Use, And Segment Forecasts, 2024 - 2030 - Product Image

Targeted DNA RNA Sequencing Market Size, Share & Trends Analysis Report By Product (NGS), By Workflow (Pre-sequencing), By Application, By Technology, By Type, By End Use, And Segment Forecasts, 2024 - 2030

  • Report
  • 100 Pages
  • Global
From
Long Read Sequencing Market by Product, Technology, Workflow, End-user, Applications - Global Forecast 2025-2030 - Product Image

Long Read Sequencing Market by Product, Technology, Workflow, End-user, Applications - Global Forecast 2025-2030

  • Report
  • 191 Pages
  • Global
From

About the Targeted Sequencing Market

Targeted sequencing is a type of genomics technology that focuses on specific regions of the genome. It is used to identify genetic variants associated with diseases, to detect mutations in cancer, and to study gene expression. Targeted sequencing is a cost-effective alternative to whole-genome sequencing, as it requires less sequencing and data analysis. It is also used in clinical diagnostics, drug discovery, and agricultural research. Targeted sequencing is a rapidly growing market, driven by advances in sequencing technology and the increasing demand for personalized medicine. Companies in the market include Illumina, Thermo Fisher Scientific, BGI, Pacific Biosciences, Oxford Nanopore Technologies, and 10x Genomics. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.